Pfizer reschedules issuance of Q3 performance report, conference call

theflyonthewall.com

Pfizer announces the postponement of the issuance of its Q312 performance report and webcast of a conference call with investment analysts, which was previously scheduled for Tuesday, October 30, at 10 a.m. EDT, due to the expected severe weather conditions associated with Hurricane Sandy. The webcast of a conference call with investment analysts has been rescheduled for Thursday, November 1 at 10 a.m. EDT. The purpose of the call is to provide an update on Pfizer’s results, as reflected in the company’s Q312 performance report, to be issued earlier that morning.

View Comments (0)